A Practical Guide to Immunoassay Method Validation
University of Gothenburg · Inserm · +23 more institutions
Abstract
Biochemical markers have a central position in the diagnosis and management of patients in clinical medicine, and also in clinical research and drug development, also for brain disorders, such as Alzheimer's disease. The enzyme-linked immunosorbent assay (ELISA) is frequently used for measurement of low-abundance biomarkers. However, the quality of ELISA methods varies, which may introduce both systematic and random errors. This urges the need for more rigorous control of assay performance, regardless of its use in a research setting, in clinical routine, or drug development. The aim of a method validation is to present objective evidence that a method fulfills the requirements for its intended use. Although…
Citation impact
- FWCI
- 12.64
- Percentile
- 100%
- References
- 14
Authors
21- UAUlf AndréassonCorresponding
University of Gothenburg
- APArmand Perret‐Liaudet
Inserm, Centre National de la Recherche Scientifique, Centre de Recherche en Neurosciences de Lyon, Université Claude Bernard Lyon 1
- LJLinda Josephine Christine van Waalwijk van Doorn
Radboud University Medical Center, Radboud University Nijmegen
- KBKaj Blennow
University of Gothenburg
- DCDavide Chiasserini
University of Perugia
Topics & keywords
- Computer science
- Medical physics
- Immunoassay
- Drug development
- Medicine
- Data mining
- Drug
- Pharmacology
- Good health and well-being
Funding
- NRNational Research Centre
- EJEU Joint Programme – Neurodegenerative Disease Research
- ZZonMw
- BFBundesministerium für Bildung und Forschung
- BFBelgian Federal Science Policy Office
- FWFonds Wetenschappelijk Onderzoek
- MDMinistero della Salute
- VVetenskapsrådet
- TBTürkiye Bilimsel ve Teknolojik Araştırma Kurumu
- NFNorges Forskningsråd
- UAUniversiteit Antwerpen
- VRVlaamse regering
- FPFondation pour la Recherche sur Alzheimer
- KNKrajowy Naukowy Osrodek Wiodacy